EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors

Lei Chen iD, Heng Lu, Farah Ballout iD, Wael El-Rifai iD, Zheng Chen, Ravindran Caspa Gokulan, Oliver Gene McDonald, Dunfa Peng iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26051992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lei Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: NIMA-Related Kinases, Gastrointestinal Neoplasms, Protein Kinase Inhibitors, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Sylvester Comprehensive Cancer Center, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) cancers, which mainly include malignancies of the esophagus, stomach, intestine, pancreas, liver, gallbladder, and bile duct, pose a significant global health burden. Unfortunately, the prognosis for most GI cancers remains poor, particularly in advanced stages. Current treatment options, including targeted and immunotherapies, are less effective compared to those for other cancer types, highlighting an urgent need for novel molecular targets. NEK (NIMA related kinase) kinases are a group of serine/threonine kinases (NEK1-NEK11) that play a role in regulating cell cycle, mitosis, and various physiological processes. Recent studies suggest that several NEK members are overexpressed in human cancers, including gastrointestinal (GI) cancers, which can contribute to tumor progression and drug resistance. Among these, NEK2 stands out for its consistent overexpression in all types of GI cancer. Targeting NEK2 with specific inhibitors has shown promising results in preclinical studies, particularly for gastric and pancreatic cancers. The development and clinical evaluation of NEK2 inhibitors in human cancers have emerged as a promising therapeutic strategy. Specifically, an NEK2 inhibitor, T-1101 tosylate, is currently undergoing clinical trials. This review will focus on the gene expression and functional roles of NEKs in GI cancers, as well as the progress in developing NEK inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NIMA-Related KinasesGastrointestinal NeoplasmsProtein Kinase InhibitorsGene Expression Regulation, NeoplasticAntineoplastic AgentsHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

NEKgastrointestinal (GI) cancersgene expressioninhibitorstherapeutic targets

Substanzen

NIMA-Related KinasesProtein Kinase InhibitorsAntineoplastic AgentsNEK2 protein, human

Autor:innen und Institutionen

  • Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
  • Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

ORCID-Profile: Lei Chen, Farah Ballout, Wael El-Rifai, Dunfa Peng

Förderung

  • NCI NIH HHS
  • Sylvester Comprehensive Cancer Center
  • NIH HHS
  • National Cancer Institute of the National Institutes of Health

Zitieren

APA

Chen, L., Lu, H., Ballout, F., El-Rifai, W., Chen, Z., Gokulan, R. C., McDonald, O. G., & Peng, D. (2025). Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051992

Vancouver

Chen L, Lu H, Ballout F, El-Rifai W, Chen Z, Gokulan RC, et al. Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051992

BibTeX
@article{Chen2025,
  author = {Chen, Lei and Lu, Heng and Ballout, Farah and El-Rifai, Wael and Chen, Zheng and Gokulan, Ravindran Caspa and McDonald, Oliver Gene and Peng, Dunfa},
  title = {Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26051992}
}
Kostenlos starten →